Key Information
Source
summary/abstract
Genetic testing is an important part of the diagnosis process for transthyretin cardiac amyloidosis (ATTR-CM)external link, opens in a new tab. It’s not only key to managing your care but also helps you determine whether others in your family have the condition or are at risk.
ATTR-CM occurs when an irregular protein called transthyretin, or TTR, is produced in the liver and builds up in the heart. This buildup stiffens the walls of the heart, making it harder for the heart to pump blood. Eventually, it can lead to heart failureexternal link, opens in a new tab.
Genetic testing can help reduce your risk of such complications, as well as protect your loved ones.